New York State Common Retirement Fund Aadi Bioscience, Inc. Transaction History

New York State Common Retirement Fund

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$1.46 - $2.31 $15,461 - $24,462	-10,590 Reduced 98.69%	141 $0
Q1 2024 May 07, 2024	BUY	$1.59 - $2.44 $936 - $1,437	589 Added 5.81%	10,731 $25,000
Q4 2023 Feb 01, 2024	SELL	$1.97 - $5.41 $45 - $124	-23 Reduced 0.23%	10,142 $20,000
Q3 2023 Nov 07, 2023	BUY	$4.84 - $7.13 $232 - $342	48 Added 0.47%	10,165 $49,000
Q4 2022 Jan 30, 2023	SELL	$11.99 - $14.5 $59 - $72	-5 Reduced 0.05%	10,117 $130,000
Q3 2022 Nov 08, 2022	BUY	$12.03 - $14.22 $1,467 - $1,734	122 Added 1.22%	10,122 $143,000
Q2 2022 Aug 04, 2022	BUY	$11.57 - $17.92 $115,700 - $179,200	10,000 New	10,000 $123,000

12.6M

23.8K

Ticker AADI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,016,800
Market Cap $78.4M
Description
Aadi Bioscience, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug candidate, FYARRO is a form of sirolimus bound to albumin. Aadi is evaluating FYARRO in cancers with known mTOR pathway activation, ...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.